US Archives - Page 104 of 130 - European Medical Journal

EU Rejects Majority of US Fast-Tracked Cancer Drugs

A recent study has spotlighted the regulatory divide between the US Food and Drug Administration’s (FDA) Accelerated Approval (AA) pathway and the European Medicines Agency’s (EMA) Conditional Marketing Authorization (CMA) process, showing stark differences in their cancer drug approvals.

Vaccine Boosters Cut Post-COVID Blood Clot Risk

A recent study reveals that COVID-19 booster shots significantly reduce the risk of developing venous thrombosis or embolism (VTE) following SARS-CoV-2 infection.

Washington Facing Dramatic Whooping Cough Spike

The Washington State Department of Health (DOH) is reporting a dramatic increase in pertussis (whooping cough) cases, underscoring the importance of vaccination, particularly for young children and infants.

Study Reveals High Risk of Preventable Surgery Errors

A new cohort study conducted across 11 U.S. hospitals has found that nearly 40% of surgical patients experience adverse events during inpatient perioperative care.

New Data on RSV Burden in U.S. Adults 75+

Respiratory syncytial virus (RSV) has caused severe illness in adults, especially among those aged 75 and older, but the burden of RSV-associated hospitalizations before vaccines were introduced is unclear.

CDC Appoints Industry To Develop Avian Flu Tests in New Agreement

An agreement has been issued by the United States Centers for Disease Control and Prevention (CDC) to partner with Alveo Technologies to develop a rapid, point-of-need diagnostic test for detecting avian influenza A(H5) in humans.

Prostate Cancer Overtreatment Among Veterans Persists

Overtreatment of prostate cancer persists among men with limited life expectancy within the Veterans Affairs (VA) health system.

The Teen Brain’s Secret Weapon Against Pain?

Resilience in adolescents with juvenile fibromyalgia (JFM) may significantly alleviate emotional symptoms, providing fresh insights for clinicians treating this complex chronic pain condition.

Clinical Implications of Metformin on COPD

Metformin, commonly prescribed for diabetes, may reduce the risks of exacerbation and hospitalization in patients with chronic obstructive pulmonary disease (COPD).

FDA Lifts Hold on COVID-Flu Combo Vaccine Trial

The U.S. Food and Drug Administration (FDA) has lifted a clinical hold on a late-stage trial of a combined COVID-19 and influenza vaccine candidate, allowing the study to resume following an investigation into a reported adverse event.